Healthcare — Federal regulators intensify healthcare oversight as FTC launches Healthcare Task Force and strikes $7B insulin pricing deal with CVS

Healthcare · 2026-03-25

A significant shift in federal healthcare oversight is emerging, marked by aggressive regulatory intervention in drug pricing and industry practices. The FTC's launch of a cross-agency Healthcare Task Force, coupled with its landmark settlement with CVS over insulin pricing manipulation, signals a new era of coordinated enforcement. This regulatory activism extends beyond pharmaceuticals, with…